| 000 | 00941 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250518080420.0 | ||
| 264 | 0 | _c20200717 | |
| 008 | 202007s 0 0 eng d | ||
| 022 | _a1526-4610 | ||
| 024 | 7 |
_a10.1111/head.13710 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCharles, James A | |
| 245 | 0 | 0 |
_aIn Response to Recommendations on the Use of Anti-CGRP Monoclonal Antibodies in Children and Adolescents. _h[electronic resource] |
| 260 |
_bHeadache _c01 2020 |
||
| 300 |
_a271-272 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAntibodies, Monoclonal |
| 650 | 0 | 4 | _aCalcitonin Gene-Related Peptide Receptor Antagonists |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aReceptors, Calcitonin Gene-Related Peptide |
| 773 | 0 |
_tHeadache _gvol. 60 _gno. 1 _gp. 271-272 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/head.13710 _zAvailable from publisher's website |
| 999 |
_c30495247 _d30495247 |
||